Reveals membrane permeability's impact on PROTAC activity in living cells, indicating improved design strategies.
Membrane permeability is critical to the function of proteolysis targeting chimeras (PROTACs), yet common methods such as the parallel artificial membrane permeability assay (PAMPA) and Caco-2 transwell assays are limited by their experimental configuration and fail to directly measure a compound's ability to access the cytosolic space of a target cell. Here, we present a method to measure the membrane permeability of unmodified PROTACs and other E3 ligase ligands directly into the cytosol of living cells. By utilizing NanoBRET live-cell target engagement in real time, we quantify permeability rates that match those from transwell systems and reveal rates that transwell setups fail to measure. Several previously undetectable BET-targeting PROTACs, with subtle structural changes, display differing permeabilities that rationalize discrepancies in live-cell degradation efficiency and cytotoxicity. Ultimately, this approach enables quantitative permeability profiling of PROTACs previously considered unmeasurable in transwell assays, providing a powerful tool to guide rational design and lead optimization.
No takes yet. Share an insight, caveat, or question.
Engstrom et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: